2020
DOI: 10.21203/rs.3.rs-92665/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Background splicing and genetic disease

Abstract: We report that low level background splicing by normal genes can be used to predict the likely effect of splicing mutations upon cryptic splice site activation and exon skipping, with emphasis on the DBASS databases, BRCA1, BRCA2 and DMD. In addition we show that background RNA splice sites are also involved in pseudoexon formation, recursive splicing and aberrant splicing in cancer. We discuss how background splicing information might inform splicing therapy.

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…However, this does not mean that splicing must be perfect. Occasional splicing errors are inevitable even in healthy cells ( Alexieva et al, 2021 ), and these aberrant transcripts are generally well-managed by error-detecting systems such as nonsense-mediated decay (NMD) ( Hug et al, 2016 )—but never without some energy cost to the cell.…”
Section: Introductionmentioning
confidence: 99%
“…However, this does not mean that splicing must be perfect. Occasional splicing errors are inevitable even in healthy cells ( Alexieva et al, 2021 ), and these aberrant transcripts are generally well-managed by error-detecting systems such as nonsense-mediated decay (NMD) ( Hug et al, 2016 )—but never without some energy cost to the cell.…”
Section: Introductionmentioning
confidence: 99%